KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Neogenomics (NEO) over the last 16 years, with Q4 2025 value amounting to $128.1 million.

  • Neogenomics' Shares Outstanding (Diluted Average) rose 113.93% to $128.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $128.1 million, marking a year-over-year increase of 113.93%. This contributed to the annual value of $128.1 million for FY2025, which is 113.93% up from last year.
  • Per Neogenomics' latest filing, its Shares Outstanding (Diluted Average) stood at $128.1 million for Q4 2025, which was up 113.93% from $128.4 million recorded in Q3 2025.
  • Neogenomics' 5-year Shares Outstanding (Diluted Average) high stood at $131.2 million for Q2 2021, and its period low was $116.2 million during Q1 2021.
  • For the 5-year period, Neogenomics' Shares Outstanding (Diluted Average) averaged around $125.3 million, with its median value being $125.6 million (2023).
  • Per our database at Business Quant, Neogenomics' Shares Outstanding (Diluted Average) surged by 2164.3% in 2021 and then crashed by 546.26% in 2022.
  • Quarter analysis of 5 years shows Neogenomics' Shares Outstanding (Diluted Average) stood at $120.0 million in 2021, then grew by 3.55% to $124.2 million in 2022, then rose by 1.03% to $125.5 million in 2023, then rose by 0.92% to $126.7 million in 2024, then increased by 1.14% to $128.1 million in 2025.
  • Its last three reported values are $128.1 million in Q4 2025, $128.4 million for Q3 2025, and $127.9 million during Q2 2025.